Actively Recruiting

Phase Not Applicable
Age: 40Years - 70Years
All Genders
Healthy Volunteers
NCT03793348

Study to Evaluate the Safety and Efficacy of the Cytrellis Micro-Coring Device for the Treatment of Moderate to Severe Facial Wrinkles

Led by Cytrellis Biosystems, Inc. · Updated on 2019-01-04

35

Participants Needed

6

Research Sites

40 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Study evaluating the efficacy of a micro coring device for the treatment of moderate to severe check wrinkles

CONDITIONS

Official Title

Study to Evaluate the Safety and Efficacy of the Cytrellis Micro-Coring Device for the Treatment of Moderate to Severe Facial Wrinkles

Who Can Participate

Age: 40Years - 70Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Males and females aged 40 to 70 years
  • Fitzpatrick Skin Type I to IV as judged by the Investigator
  • Cheek wrinkles at least score 3 on the Lemperle Wrinkle Assessment Scale as judged by the Investigator
  • Able to provide written informed consent and willing to comply with study procedures and follow-up visits
Not Eligible

You will not qualify if you...

  • Lesions suspicious for malignancy or presence of actinic keratosis, melasma, vitiligo, cutaneous papules/nodules, or active inflammatory lesions in treatment areas
  • History of keloid formation or hypertrophic scarring
  • Trauma or surgery to treatment areas within past 6 months
  • Scar present in treatment areas
  • Silicone injections in treatment areas
  • Dermal fillers, fat, botulinum toxin, or other skin treatments within past 6 months in treatment areas
  • Active smokers or quit smoking within 3 months prior to treatment
  • Active, chronic, or recurrent infection
  • History of compromised immune system or current immunosuppressive treatment
  • Sensitivity to analgesics, Aquaphor�, topical or local anesthetics, chlorhexidine, povidone-iodine, or epinephrine
  • Excessive sun exposure or tanning bed/cream use within 30 days prior to treatment
  • Treatment with aspirin or blood thinning agents within 14 days prior to treatment
  • History or presence of significant bleeding disorders
  • Any condition that interferes with safety, efficacy assessment, or participant ability
  • Use of investigational device or agent within 30 days before treatment or during study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

Laser and Skin Surgery Center of Northern California

Sacramento, California, United States, 95816

Active, Not Recruiting

2

AboutSkin Research, LLC

Greenwood Village, Colorado, United States, 80111

Not Yet Recruiting

3

Miami Dermatology & Laser Institute

Miami, Florida, United States, 33173

Active, Not Recruiting

4

Laser and Skin Surgery of New York

New York, New York, United States, 10016

Actively Recruiting

5

The Office of Brian Biesman, M.D.

Nashville, Tennessee, United States, 37203

Active, Not Recruiting

6

Dallas Plastic Surgery Institute

Dallas, Texas, United States, 75231

Not Yet Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here